Share:
Peer-Reviewed Publication
J Diabetes Sci Technol2025;19322968251340664.May 13, 2025Journal Article

Assessing the Financial Sustainability of a Virtual Clinic Providing Comprehensive Diabetes Care.

Paul Dupenloup1, Grace Guan1, Grazia Aleppo2, Richard M Bergenstal3, Korey Hood4, Davida Kruger5, Teresa McArthur6, Beth Olson7, Sean Oser8, Tamara Oser8, Ruth S Weinstock9, Robin L Gal10, Craig Kollman10, David Scheinker1,11,12,13
1Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.
2Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
3International Diabetes Center, Minneapolis, MN, USA.
4School of Medicine, Stanford University, Stanford, CA, USA.
5Henry Ford Health System, Detroit, MI, USA.
6Cecelia Health, New York, NY, USA.
7Lagoon Health, Minneapolis, MN, USA.
8School of Medicine, University of Colorado, Aurora, CO, USA.
9SUNY Upstate Medical University, Syracuse, NY, USA.
10Jaeb Center for Health Research, Tampa, FL, USA.
11Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, USA.
12Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.
13Department of Medicine, Division of Biomedical Informatics Research, Stanford University, Stanford, CA, USA.

Abstract

INTRODUCTION: The Virtual Diabetes Specialty Clinic (VDiSC) study demonstrated the feasibility of providing comprehensive diabetes care entirely virtually by combining virtual visits with continuous glucose monitoring support and remote patient monitoring (RPM). However, the financial sustainability of this model remains uncertain. METHODS: We developed a financial model to estimate the variable…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.